PETALING JAYA: The emergence of Singapore billionaire Peter Lim Eng Hock as the second biggest shareholder in TMC Life Sciences Bhd
is unlikely to spur any change in fortunes any time soon in the loss-making fertility firm, according to analyst reports.
OSK Research, in its report yesterday, said TMC, with financial year ending Dec 31, is likely to record losses this year and minor earnings next year.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
